Tag: clinical translation
-
Ireland launches Phase 2 of national Precision Oncology program to accelerate personalized cancer care
Ireland marks a new chapter in personalized cancer care with Phase 2 of Precision Oncology Ireland On 8 October, Ireland strengthened its commitment to precision medicine with the launch of Phase 2 of Precision Oncology Ireland (POI), the country’s leading and largest cancer research program. The initiative, announced by James Lawless TD, Minister for Further…
-
Ireland Expands Precision Oncology Ireland: Phase 2 Launch Poised to Transform Cancer Care
Ireland Launches Phase 2 of its National Precision Oncology Program On 8 October, Ireland marked a significant milestone in its fight against cancer with the launch of Phase 2 of Precision Oncology Ireland (POI). The event signals a bold expansion of the country’s leading cancer research program, built to advance personalised cancer research and patient…
-
Next‑gen imaging promises sharper, deeper views of living tissues
A bold step toward noninvasive, high‑resolution tissue imaging A University of Arizona research team is advancing a transformative approach to viewing living tissues noninvasively. With nearly $2.7 million from the NIH Common Fund Venture Program, the interdisciplinary effort aims to push the boundaries of optical imaging so clinicians can see deeper into skin and soft…
-
POI Phase 2: €28m to Accelerate Ireland’s Precision Oncology
Ireland’s Largest Cancer Research Programme Enters Phase 2 Ireland is accelerating its commitment to personalized cancer care as Precision Oncology Ireland (POI) enters its second phase. With a newly approved €28 million co-funding package, POI aims to scale its cross-sector model and deepen patient involvement, turning research breakthroughs into real-world diagnostics and treatments. What POI…
-
Next-Generation Imaging Promises Sharper, Deeper Views of Living Tissues
Breakthrough in Noninvasive Imaging Targets Deeper Tissue Insights A University of Arizona research team has received nearly $2.7 million from the NIH’s Common Fund Venture Program to push the boundaries of noninvasive optical imaging. Led by Florian Willomitzer, associate professor of optical sciences, and Dr. Clara Curiel-Lewandrowski of the U of A Comprehensive Cancer Center,…